title: Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation.
authors: Department of Internal Medicine, Asker and Baerum Hospital, Rud, Norway. arnljot.tveit@broadpark.no
authors: Arnljot
authors: A
authors: Tveit
authors: Ingebjørg
authors: I
authors: Seljeflot
authors: Irene
authors: I
authors: Grundvold
authors: Michael
authors: M
authors: Abdelnoor
authors: Pal
authors: P
authors: Smith
authors: Harald
authors: H
authors: Arnesen
mesh_terms: D000368:Aged; D001281:Atrial Fibrillation / Q000097:blood / Q000628:therapy*; D015992:Body Mass Index; D004554:Electric Countershock; D005260:Female; D006801:Humans; D008297:Male; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D008875:Middle Aged; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood*; D010959:Tissue Plasminogen Activator / Q000097:blood; D016896:Treatment Outcome; D014841:von Willebrand Factor / Q000032:analysis
chemical_list: D017395:Plasminogen Activator Inhibitor 1; D014841:von Willebrand Factor; D010959:Tissue Plasminogen Activator; D020780:Matrix Metalloproteinase 9